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ABSTRACT
OBJECTIVE: To examine the HIV care cascade among trans women and travestis in São Paulo 
– Brazil, the most populous city in South America. 
METHODS: Using data from a cross-sectional study carried out between November 2016 and 
May 2017 in the city of São Paulo (Divas Research). Respondent driven sampling (RDS) was 
used to recruit 386 transgender women and travestis who participated in a HIV risk survey and 
were tested for HIV. The cascade was defined as HIV prevalence, HIV diagnosed, Antiretroviral 
(ART) Prescription, and currently on ART. A multiple analysis model was conducted to identify 
the association between sociodemographics and the cascade gaps. 
RESULTS: Of the trans women living with HIV, 80.9% were already diagnosed, 76.6% of them 
had been prescribed, of which 90.3% were currently on treatment. Those who were registered 
in care had a higher rate of ART (aPR 2.06; 95%CI 1.09-3.88). Trans women between 31-40 years 
old (aPR 1.65; 95%CI 1.09-2.50) and those older than 40 (aPR 1.59; 95%CI 1.04-2.43) had higher 
prevalence of ART. 
CONCLUSIONS: Our data suggest an increase in the testing and treatment policy 
implementation among trans women in the city of São Paulo, although gaps have been found 
in the linkage to care. However, young trans women and those not registered in health care 
service may benefit from efforts to engage this part of the population in care to improve HIV 
treatment and care outcomes. 
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INTRODUCTION
Among the different populations at high risk of HIV infection, people who identify as 
transgender women and travestis have one of the highest HIV infection rates around the 
world¹. Due to gender non-conformity (non-recognition of the gender assigned at birth as 
their gender identity) and the challenge of persuading the society this is a valid identity 
to be fully respected, transgender women and travestis are constantly stigmatized, 
experience difficulties in their insertion in different institutions and contexts, including 
health services2–4.
In Brazil, different modalities of discrimination and prejudice, such as transphobia and 
unprotected sex, place this population at a higher risk of HIV∕AIDS and other sexually 
transmitted diseases5. A study conducted in 2016 with transgender women in Rio de Janeiro 
identified a difference between the reported and confirmed HIV prevalence (24.2% and 31.2%, 
respectively), suggesting that a part of the population did not know their serological status, 
or did not have access to prior HIV testing before participating in the study6. Furthermore, 
the prevalence of HIV infection in transgender women is not documented in a systematic 
way by health services, neither by most surveillance systems (which frequently do not 
report the category “transgender”), resulting in a lack of information about the epidemic. 
Gathering specific epidemiological data about trans women and travestis can help identify 
the magnitude of this epidemic, its trends, and allow for the collaboration with executive 
health plans and reformulation of properly tailored public policies7,8.
An important mechanism to assess the profile of HIV infection in different countries is the 
HIV Care Continuum Cascade, a tool that uses simple mathematical modeling to illustrate 
a chain of events from the awareness of HIV infection to the final objective, HIV health 
care, which is used to get the undetectable viral load9,10. 
The construction of a HIV care cascade is important to identify gaps that limit access to 
diagnostic and treatment services, since there is limited information on the health care 
of transgender women living with HIV. Considering the stigmatization and prejudice this 
population lives, it is imperative to analyze the features of the epidemic, produce data on 
the number and proportion of people living with HIV, and access treatment services and 
their results to evaluate the health care offered to this population. 
In Brazil, there is a shortage of specific research on this population group, especially travestis, 
and their knowledge about health issues. This study aimed to analyze the HIV care cascade 
for trans women and travestis living in São Paulo, Brazil and to identify factors associated 
with the major gaps in the care continuum. 
METHODS
The data of this study were collected from the project “Study of national coverage of HIV, 
behaviors, attitudes, practices and prevalence of syphilis, hepatitis B and C between travestis 
(Divas Research),” conducted between November 2016 and May 2017 in the city of São Paulo.
A total of 386 transgender women and travestis were recruited using Respondent-Driven 
Sampling (RDS), method that relies on social networks, with participants inviting 
other members from their population to be enrolled in the research. Five “seeds” (first 
participants) were selected from São Paulo, which were identified in a previous formative 
research. At the field, each participant was oriented on the inclusion criteria, reading 
and signing the informed consent form (ICF). Additionally, each participant received 
three invitations, which initiate the recruitment chains. This sampling method assumes 
that members of the targeted community are more adept at locating and recruiting 
other participants11. Monetary support was given to the participants for transportation 
and recruitment expenses: each participant received $10 after their first interview, and 
3
HIV care continuum among trans women in Brazil Rocha ABM et al.
https://doi.org/10.11606/s1518-8787.2020054002374
they could potentially receive an additional $10 for each referral that participates in the 
research. More details about the methodology can be found in a previous article12. After 
the interview, participants are quickly tested for HIV and other sexual transmitted 
infections (STI). Any person with a positive result is immediately linked to care to proceed 
diagnostics and appropriate treatment, when applicable. 
Trained interviewers applied structured questionnaires, which were used for data 
collection. Sociodemographic factors assessed in this study were gender identity, skin 
color, education level, income, age, housing situation, relationship status, and health 
care service registration. The variable “housing situation” considered the type of housing, 
classifying participants as “stable” (homeowners, renting, or living with relatives) or 
“unstable” (hotel, occupation, shelter, or living in their workplace). The variables composing 
sociodemographics represent what could interfere with the outcomes related to HIV 
infection and treatment, along with those presented in the Brazilian Ministry of Health 
report of clinical monitoring of HIV in Brazil13.
The construction of the HIV care cascade was conducted using variables available in the 
questionnaire that correspond with those used in classic models of cascades9. The variables 
chosen were the proportion of trans women living with HIV (HIV prevalence), proportion 
of trans women previously aware of their serological status (HIV diagnosed), proportion of 
Antiretroviral (ART) prescription, and proportion of current adherence to ART (medication 
intake). This study did not have access to the viral load count of the participants, and it did 
not include a specific question that could measure retention in care. 
In the statistical analysis, as assumed in RDS sampling procedures, a weight for each 
participant was defined using the estimator RDS II from the software RDS Analyst version 
12. Descriptive statistics, association tests, and mathematical models were performed 
using complex sampling design procedures, which consider the secondary dependence 
to the underlying chain-referral process. Categorical variables were described by relative 
frequencies and respective confidence intervals. Bivariate analysis was used to identify 
factors associated with the gaps of HIV care cascade using Poisson regression14. In the 
multiple analysis model, we included variables with p < 0.20 and those found in previous 
literature. A 5% significance level was considered. The analysis considered the sampling 
design and was done in Stata, version 13.
The study protocol was reviewed and approved by Sergio Arouca National School of 
Public Health (ENSP/FIOCRUZ) Research Ethics Board (CAAE-49359415.9.0000.5240). All 
participants provided written informed consent, participants could withdraw consent at 
any stage of the process or skip any questions or laboratorial testing if considered it too 
personal, sensitive or distressing. 
RESULTS
Our study enrolled a total of 386 participants. Most of them self-identified as travesti 
(50.5%) and trans women (39.9%). Most of our sample was composed of adults from 25 to 
40 years, and 23.6% were classified as youth (24 years or younger). Skin color was also self-
declared, 50.5% of the participants identified as mixed race and 15.9% identified as black. 
The data collected for educational status indicated that almost half of the respondents had 
some high school (47.5%) and only 12% had attended a university or college. Information 
collected regarding income indicated that 36.3% of the participants earned less than 242.22 
US dollars per month, which constitute the minimum wage in Brazil. Additionally, 30.4% 
of the participants reported unstable housing. Most participants were single (62.8%) and 
registered in primary health care services (80.5%) (Table 1).
A total of 148 participants tested positive for HIV, indicating a 38% (95%CI: 30.9-45.6) of 
prevalence, of which 80.9% (95%CI: 67.2-89.7) had been previously diagnosed and were aware 
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of their positive status. Of this, 76.6% (95%CI: 61.6-87.0) had received ART prescription, and 
90.8% of those (95%CI: 82.0-95.5) reported currently taking ART. (Figure 1). 
The total of 80.5% participants were registered in health care services, among them 88.2% 
were aware of their positive status, 78.9% received ART prescription, and 94.3% were 
currently on ART at the time of the survey. We observed that only 64.6% of youth were taking 
ART, while among all other age brackets this proportion was higher than 90% (Table 2).
No statistically significant association was found between the awareness of HIV infection 
and ART prescription. In the bivariate analysis, no statistically significant association 
was found between any sociodemographic characteristics and ART prescription. Also, 
in bivariate analysis we found that individuals who receive less than the minimum wage as 
Table 1. Sociodemographic characteristics of trans women and travestis living in São Paulo, Brazil, 
2017 (n = 386)
Variable  %* 95%CI
Gender 
Woman 9.32 5.93–14.37 
Trans woman 39.95 32.95–47.73 
Travesti 50.5 42.94–58.03 
Skin color 
White 30.02 23.38–37.61 
Black 15.91 11.43–21.71 
Mixed 50.55 42.99–58.09 
Other (Indigenous/Yellow) 3.53 1.77–6.89 
Education 
More than high school 12.04 7.63–18.47 
High school 40.41 33.17–48.09 
Less than high school 47.55 40.09–55.13 
Income (minimum wage - MW)
More than three MW 14.74 10.06–21.09 
Between one and three MW 48.95 41.43–56.53 
Less than one MW 36.31 29.52–43.68 
Age 
< 24 23.62 17.82–30.61 
25–30 32.39 25.65–39.95
31–40 29.05 22.61–36.47 
> 40 14.94 10.47–20.86 
Housing situation 
Stable 69.61 62.56–75.85 
Unstable 30.39 24.15–37.44
Relationship status 
Single 62.82 55.08–69.95 
Dating 14.63 9.86–21.17 
Married 21.62 15.82–28.82 
Other 0.93 0.29–2.96 
Registered in health care service
No 19.51 13.87–26.72 
Yes 80.49 73.28–86.13 
* Weighted proportion using RDS complex sampling procedures.
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ART: antiretroviral 
* Percentage of the respondent driven sampling population estimates.






















Table 2. Sociodemographic characteristics by HIV diagnosed, antiretroviral (ART) prescription and currently taking ART (row) for trans 






Currently taking ART 
p
%* 95%CI %* 95%CI %* 95%CI
Gender   0.382   0.675   0.393
Woman 59.0 20.6–88.9  86.1 50.3–97.4  76.8 30.4–96.2  
Trans woman 86.4 60.6–96.3  72.3 47.2–88.5  94.5 76.4–98.9  
Travesti 80.6 60.9–91.8  79.4 58.3–91.4  89.8 76.8–95.9  
Skin color   0.697   0.691   0.134
White 75.8 43.5–92.8  84.6 43.5–97.5  94.7 79.4–98.8  
Black 89.0 63.8–97.4  72.3 43.6–89.8  100 -  
Mixed 81.1 62.7–91.7  73.5 52.9–87.3  89.0 75.6–95.5  
Other (Indigenous/Yellow) 90.8 62.8–98.3  100 -  56.5 11.9–92.5  
Education   0.968   0.745   0.694
More than high school 76.9 27.7–96.6  69.9 20.9–95.3  87.5 43.4–98.5  
High school 81.3 54.5–94.0  83.3 56.2–95.1  94.2 79.6–98.6  
Less than high school 81.5 63.3–91.9  73.5 52.8–87.3  88.8 74.4–95.5  
Income (minimum wage - MW)   0.061   0.394   0.082
More than three MW 50.8 21.4–79.8  95.8 85.4–98.9  100 -  
Between one and three MW 82.7 58.5–94.3  74.7 49.2–90.1  96.9 86.5–99.4  
Less than one MW 89.0 69.7–96.6  74.7 52.7–88.7  83.3 66.8–92.6  
Age   0.098   0.159   0.002
< 24 69.5 38.5–89.3  75.9 48.2–91.5  64.6 33.4–86.9  
25–30 74.3 48.3–89.9  71.6 43.1–89.4  93.4 75.8–98.8  
31–40 89.8 74.7–96.3  62.1 30.9–85.7  99.0 92.7–99.8  
> 40 98.5 89.3–89.8  100 -  100 -  
Housing situation   0.871   0.760   0.260
Stable 79.9 60.9–91.1  74.8 53.1–88.7  93.8 83.4–97.8  
Unstable 81.8 58.7–93.5  78.8 56.4–91.5  86.6 68.9–94.9  
Relationship status   0.932   0.680   0.474
Single 80.6 61.9–91.4  80.0 62.4–90.7  93.8 84.4–97.7  
Dating 77.6 41.6–94.4  80.2 33.6–97.0  89.9 62.2–97.9  
Married 83.6 48.6–96.5  64.9 31.1–88.4  82.5 49.9–95.7  
Other 100 -  84.2 32.4–98.3  87.5 36.1–98.8  
Registred in health care service   0.003   0.255   < 0.001
No 45.1 17.5–76.0  55.3 16.6–88.5  43.4 13.8–78.5  
Yes 88.2 75.2–94.8  78.9 63.3–89.0  94.3 85.9–97.8  
* Weighted proportion using RDS complex sampling procedures.
Bolded values:  Statistically significance. 
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income had a lower prevalence ratio of currently taking antiretroviral medication (PRR 0.83; 
95%CI:0.71-0.97) (Table 3).
In the multivariate regression, individuals who self-identify as trans women have lower 
adjusted prevalence ratio of having ART prescription (aPR 0.56; 95%CI: 0.31-0.98) when 
compared with those who self-identify as women. Furthermore, the older individuals 
(more than 40 years old) had a higher adjusted prevalence ratio of having ART prescription 
(aPR 1.56; 95%CI: 1.06-2, 30). According to multivariate analysis, age groups between 
31-40 (aPR 1.65; 95%CI: 1.09-2.50) and older than 40 years old (aPR 1.59; 95%CI:1.04-2.43) 
Table 3. Univariate and multivariate analysis for having antiretroviral (ART) prescription and ART uptake among trans women in São Paulo, 
Brazil, 2017.
Variable
Have ART prescription Currently take ART 
PRR 95%CI aPRR 95%CI PRR 95%CI aPRR 95%CI
Gender         
Woman Reference - Reference - Reference - Reference -
Trans woman 0.84 0.56–1.24 0.56 0.31–0.98 1.23 0.76–1.98 1.16 0.90–1.49 
Travesti 0.92 0.66–1.27 0.64 0.37–1.11 1.16 0.72–1.88 1.15 0.90–1.47 
Skin color         
White Reference - Reference - Reference - Reference -
Black 0.85 0.54–1.34 0.73 0.51–1.05 1.05 0.97–1.14 0.99 0.86–1.14 
Mixed 0.86 0.59–1.27 0.89 0.68–1.15 0.93 0.82–1.07 0.97 0.85–1.11
Other (Indigenous/
Yellow)
1.18 0.87–1.59 1.50 0.91–2.45 0.59 0.22–1.59 0.98 0.51–1.87 
Education         
More than High 
School
Reference - Reference - Reference - Reference -
High School 1.19 0.59–2.37 1.00 0.66–1.54 1.07 0.80–1.43 1.12 0.86–1.47 
Less than High 
School 
1.05 0.52–2.10 0.79 0.51–1.24 1.01 0.75–1.36 1.02 0.75–1.39 
Income (minimum wage - MW)     
More than three MW Reference - Reference - Reference - Reference -  
Between one and 
three MW
0.78 0.58–1.04 0.78 0.58–1.04 0.96 0.92–1.01 0.96 0.81–1.14 
Less than one MW 0.77 0.60–1.00 0.66 0.43–1.03 0.83 0.71–0.97 0.81 0.67–0.98 
Age         
< 24 Reference - Reference - Reference - Reference -
25–30 0.94 0.60–1.47 0.96 0.62–1.48 1.44 0.90–2.30 1.34 0.92–1.94 
31–40 0.81 0.46–1.44 0.81 0.48–1.37 1.53 0.96–2.42 1.65 1.09–2.50 
> 40 1.31 0.98–1.76 1.56 1.06–2.30 1.54 0.97–2.44 1.59 1.04–2.43 
Housing situation         
Stable Reference - Reference - Reference - Reference -
Unstable 1.05 0.76 -1.46 1.17 0.82–1.66 0.92 0.78–1.08 1.03 0.91–1.17 
Relationship status         
Single Reference - Reference - Reference - Reference -
Dating 1.00 0.64–1.56 1.11 0.64–1.93 0.95 0.79–1.14 1.05 0.82–1.35 
Married 0.81 0.47–1.37 0.96 0.67–1.38 0.87 0.66–1.16 0.85 0.70–1.03 
Other 1.05 0.69–1.59 1.22 0.62–2.40 0.93 0.67–1.28 0.82 0.57–1.16 
Registred in health care service       
No Reference - Reference - Reference - Reference -
Yes 1.42 0.62–3.27 1.63 0.83–3.17 2.17 0.89–5.28 2.06 1.09–3.88 
Bolded values: Statistically significance.
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presented higher adjusted prevalence ratio of taking the medicine. Additionally, 
receiving less than the minimum wage of income negatively affects ART usage (aPR 0.81; 
95%CI: 0.67-0.98). Being registered in health care services had a higher adjusted prevalence 
ratio of having ART prescription when compared with not being registered (aPR 2.06 
95%CI: 1.09-3.88) (Table 3).
DISCUSSION
Over a third of trans women and travestis in our sample are living with HIV, which is similar 
to what was found in another study conducted in a different  Brazilian city, Rio de Janeiro, 
that reported a similar HIV prevalence (31.2%) for this population7. A recent meta-analysis 
estimated a worldwide HIV prevalence of 19.1% among transgender women1. The results 
of our study indicate a higher HIV prevalence for trans women and travestis in São Paulo 
compared with the pooled worldwide data. 
The HIV care cascade indicators show a suboptimal value of HIV infection diagnosis but 
a slightly better figure of engagement in medical treatment according to the 90-90-90 
goals15. Our results of 80.9% of HIV diagnosed and 90.8% of trans women currently on 
ART are better than those found in the Brazilian National Cascade, in which 84% of the 
general population living with HIV is diagnosed and 63% is currently taking ART13. One 
must remark that national data summarize information from a heterogeneous pool of 
specialized/referral services as well as services providing care and management for a broad 
set of people living with AIDS. On the other hand, our study deals with data originated 
exclusively from participants living in the city of São Paulo, located in the state of São 
Paulo, which is consistently showing better indicators, compared with other Brazilian 
states, being able to maintain a dedicated and multi-professional team engaged in data 
collection and care provision.  
In our study no statistical ly signif icant association was found between the 
sociodemographic factors and HIV awareness, suggesting that these factors may not 
interfere individually with the diagnosis in our sample, whereas other study found 
that factors such as young age negatively interfered with HIV testing, with people 
under 18 years old having less chance of being tested when compared with the older 
ones5. Alternatively, our sample may lack statistical power to indicate some potential 
associations or may be biased by bottlenecks and their associate design effects that may 
be relevant on any chain-referral based-study16.
The results presented in this study may be one of the positive consequences of the national 
public policy established in 2013 addressing the health care needs of the LGBT population, 
which contributed to the implementation of testing services and campaigns for the 
transgender population at national and local levels17. This policy is focused on preventive 
actions for groups affected by a high burden of HIV infection in Brazil, including campaigns 
aiming to reduce stigma and dedicated services available to trans women, scaling up HIV 
testing offered by public services and by non-governmental organizations. Such changes 
may have led to an increase in HIV testing by the transgender population in São Paulo, 
but these results do not necessarily were translated into a greater referral for treatment 
services18. It is too soon to ascertain the effect of broad interventions on a population facing 
long-entrenched prejudice and stigma.  
The major gap in our cascade is related to ART prescription. We observed that 23.4% of 
the trans women in São Paulo who were diagnosed with HIV reported not having ART 
prescription, that is, they did not receive medical care. This result may show a failure in the 
linkage to care; however, it is not a direct measure of this phenomenon. Note that the absence 
of prescription is not exclusively related to the difficulty in accessing medical services, but 
also to the low retention at health services as a consequence of stigma and discrimination 
faced by this population, especially the ones related to HIV19.
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In the multivariate analysis, individuals who self-identified as trans women were less likely 
to receive ART prescription when compared with those who self-identify as women20. This 
may reflect the individual’s capability to appear and to be treated as her preferred gender, 
protecting them of being discriminated. It is known that gender-affirming care and the use 
of correct pronouns can improve health and quality of life for transgender people21. 
The negative effects of HIV on this population, including the HIV transmission may be 
reduced with appropriate medical care, respecting gender identity, and introducing an 
early antiretroviral therapy22.  
Traditional cascades do not rely on ART prescription in its construction but assessing this 
variable may be useful when dealing with stigmatized populations, as a proxy of individual’s 
attendance to a consultation for HIV treatment. 
Furthermore, older individuals are more likely to receive prescription and take the 
medication in comparison to the younger ones. This result is similar to HIV care continuum 
cascades for general Brazilian population, in which older individuals present higher rates 
of ART uptake13. A qualitative study conducted with transgender youth, presented several 
barriers to access HIV services and to start ART treatment, such as unstable socioeconomic 
situation, fear of lack of confidentiality, low awareness of available services, and societal 
oppression23. In another care cascade of transgender women from San Francisco, similar 
association between age and enrollment in HIV care was found24. These data indicate the 
need for policies and strategies that improve the access to treatment for young transgender 
women, probably in their gender transition phase, considering that age seems to be a 
determinant factor in HIV care for this population. 
More than 90% of our sample is currently on ART, suggesting we are reaching targeted 
values to the 90-90-90 goals. This indicates that a significant proportion of trans women 
and travestis in the city of São Paulo have access to HIV care; however, there is a lack of 
information in the process of linkage to services.  We found that trans women who receive 
less than the minimum wage (< U$250/month) had fewer chances of being currently on 
ART, illustrating the effect of socioeconomic situation on transgender health. 
Thus, people registered to health care services presented a statistically significant 
association with medication uptake, showed by a greater prevalence ratio of using ART 
for trans women registered in a health services and by the fact that more than 90% of 
the trans women who take the medication are enrolled in health services. Since in Brazil 
HIV medications are only dispensed by the Unified Health System (SUS), which requires 
the registration of users in specialized HIV/AIDS care services, HIV treatment is closely 
associated with being enrolled in public health services18. Therefore, it is not possible to use 
this finding to document that trans women are officially bounded to health services, but 
it is possible to infer that they are accessing one of the available gateways to health care. 
As a cross-sectional study, it is impossible to assess the directionality of associations. This 
study neither quantified the viral load of the participants nor the information about linkage 
to care in the questionnaire, which compromise the optimal construction of the classic care 
continuum cascade. Notwithstanding, there is a lack of studies analyzing care cascades 
among trans women in the literature. This is the first study to design a care continuum for 
trans women and travestis in São Paulo, the largest city in Latin America, and the second 
study of its kind in Brazil.
The results from this study suggest that an increase in HIV testing and the implementation 
of policies aimed to enhance the treatment among trans women and travestis in São Paulo 
city are sorely necessary to offer an acceptable, humane, and quality healthcare to this 
population. Young trans women and those not registered in health care services may 
benefit from multi-level efforts to engage this part of the population in care, providing 
health services that meet the demands of this population and be prepared to receive it, 
improving HIV care outcomes. 
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